|
US7223739B1
(en)
|
1995-06-07 |
2007-05-29 |
Powderject Vaccines, Inc. |
Adjuvanted genetic vaccines
|
|
US7294338B2
(en)
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
FR2751227B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
|
EP0863151A1
(en)
*
|
1997-02-12 |
1998-09-09 |
Akzo Nobel N.V. |
"Canine parvovirus dna vaccines"
|
|
CA2223029A1
(en)
|
1997-02-12 |
1998-08-12 |
Akzo Nobel Nv |
Canine parvovirus dna vaccines
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU753688B2
(en)
*
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
EP1002103B1
(en)
|
1997-08-04 |
2007-10-17 |
Cell Genesys, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
|
JP2001520170A
(ja)
|
1997-10-16 |
2001-10-30 |
ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム |
Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
|
|
EP1035867A1
(en)
*
|
1997-12-02 |
2000-09-20 |
Powderject Vaccines, Inc. |
Transdermal delivery of particulate vaccine compositions
|
|
EP1078053B1
(en)
*
|
1998-05-14 |
2005-09-28 |
Coley Pharmaceutical GmbH |
METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
|
|
US6881723B1
(en)
|
1998-11-05 |
2005-04-19 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
AU3593200A
(en)
|
1999-02-09 |
2000-08-29 |
Powderject Vaccines, Inc. |
(mycobacterium tuberculosis), immunization
|
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
|
US7078388B2
(en)
|
2000-01-21 |
2006-07-18 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
US7927840B2
(en)
*
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
|
ES2890882T3
(es)
*
|
2002-10-16 |
2022-01-24 |
Gen Probe Inc |
Composiciones y procedimientos para detectar el virus del Nilo occidental
|
|
CA2527756C
(en)
*
|
2003-05-15 |
2014-05-06 |
Japan Science And Technology Agency |
Immunostimulating agents
|
|
JP4817599B2
(ja)
*
|
2003-12-25 |
2011-11-16 |
独立行政法人科学技術振興機構 |
免疫活性増強剤とこれを用いた免疫活性の増強方法
|
|
WO2007035778A2
(en)
|
2005-09-19 |
2007-03-29 |
Histogenics Corporation |
Cell-support matrix and a method for preparation thereof
|
|
ES2352534T3
(es)
*
|
2007-12-28 |
2011-02-21 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
PARVOVIRUS DOTADO DE UN GENOMA ENRIQUECIDO EN CpG ÚTIL PARA EL TRATAMIENTO DEL CÁNCER.
|
|
US9550818B2
(en)
|
2012-04-27 |
2017-01-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for use of vascular endothelial growth factor antagonists
|
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|